A comparison of six approaches for measuring utility values among patients with locally advanced cervical cancer.

Kanyarat KatanyooMontarat ThavorncharoensapUsa ChaikledkaewArthorn Riewpaiboon

Published in: Expert review of pharmacoeconomics & outcomes research (2021)

TTO, VAS, EQ-5D-3L and EQ-5D-5L could not be used interchangeably in LACC patients. The impact of using different instruments on economic evaluation findings warrants further investigation.

Keyphrases

end stage renal disease
locally advanced
ejection fraction
squamous cell carcinoma
newly diagnosed
chronic kidney disease
patient reported outcomes
prognostic factors
peritoneal dialysis
radiation therapy
clinical trial
lymph node